IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: In Vitro & In Vivo Diagnostic Substances
|
ADRTSO:
|
MarketCap:
150349062.00
|
Beta:
|
52 Week High:
15.6
|
52 Week Low:
7.75
|
52 Week Change:
0.15522384621586438
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
1915637
|
Dividend Rate:
0.49455025125628144
|
Dividend Yield:
N/A
|
ExDividend Date:
2021-11-30
|
Latest EPS:
|
Latest EPS Date:
9 Nov 2022
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
N/A
|
ttmEPS:
0
|
Revenue:
$53.164M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
-
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
-
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
0.15
|
Price To Book:
2.61
|
Short Ratio:
1.42
|
PE Ratio:
0
|
Employees:
636
|
1Y Guesstimate
10.461:1.0:2
|
|
|
|
|
|
|
|
|
